Darmiyan

Curated by Signal

Platform for presymptomatic diagnosis of neurodegenerative disorders

Overview

Darmiyan provides a platform for presymptomatic diagnosis of neurodegenerative disorders, with precise quantification and localization of abnormality in the brain. It generates dynamic maps of distribution kinetics in the brain and can be used for novel drugs and biomolecules discovery and testing. The imaging solution allows users to identify areas of neuro degeneration and can be helpful for MRI image analysis.

Key facts

Founded: 2016
Headquarters: San Francisco, United States
Stage: Sign up to view
Industry: Health Technology

Business model

2 products and services: Sign up to view

Contact

Primary office: Sign up to view
Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Qardio
Digital remote health monitoring tool and device for healthcare professionals
Health TechnologySan Francisco, United States
HotSpot Therapeutics
Developer of a platform for protein function analysis
Health TechnologyBoston, United States
Pickle
Job platform that provides personalized matches for clinicians across various healthcare settings
Health TechnologyDover, United States

About Darmiyan

What does Darmiyan do?

Darmiyan provides a platform for presymptomatic diagnosis of neurodegenerative disorders, with precise quantification and localization of abnormality in the brain.

Where is Darmiyan headquartered?

Darmiyan is headquartered in San Francisco, United States.

When was Darmiyan founded?

Darmiyan was founded in 2016.

Which sector is Darmiyan in?

Darmiyan operates in Health Technology.

Who are Darmiyan's competitors?

Companies similar to Darmiyan include Qardio, HotSpot Therapeutics, and Pickle.